F00923 RSV Vaccine Trial
Fusion Norwood
RSV (Respiratory Syncytial Virus) is a cold virus that can be especially harmful to the elderly. Fusion Clinical Research are trialling a potential new vaccine against RSV and are looking for participants to help with this trial!
We are looking for healthy adults aged between 18-59 in Part 1 and aged between 60-85 in Part 2 of this trial. If you are interested in participating in this trial, please contact us or fill out an Expression of Interest form today.
Eligibility requirements
- Age: 18 - 85
- Sex: Males & Females
- BMI: 18.5 - 35
- Medical History: No previous RSV vaccine
Payment/Remuneration
- $1300 - $1350 depending on which group you are assigned to and if you complete the trial.
How to apply
To register your interest in this trial, please complete this form, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.